Medaphor Group PLC Director Appointment (0049V)

TIDMMED

RNS Number : 0049V

Medaphor Group PLC

30 October 2017

MedaPhor Group plc

("MedaPhor" or the "Company")

Director Appointment

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces the appointment of Andrew Charles Barker as a Non-Executive Director effective immediately. Upon joining, Andrew will succeed David Baynes as Chairman of the Remuneration Committee, while David will retain the Chairmanship of the Company's Audit Committee.

Andrew, 59, has over 30 years' experience in senior management of technology and software businesses and in venture capital, having been involved in the early stages of internet computing with Sun Microsystems in Silicon Valley, later going on to help build Intel's venture arm in the UK.

He is an experienced NED and investor in early stage companies with disruptive technology. His portfolio has a med-tech focus and, in addition to his position as a Director of Intelligent Ultrasound Limited (acquired by MedaPhor on 6 October 2017, RNS number: 8775S), Andrew is the Chairman of Brainomix, a University of Oxford medical imaging spin out and a Partner of Anchard Associates LLP.

Riccardo Pigliucci, Chairman of MedaPhor, said: "I am very pleased to welcome Andrew to the Board. In addition to bringing a wealth of relevant experience, his appointment highlights the importance of Intelligent Ultrasound to the enlarged group and will facilitate its integration into MedaPhor."

Other than that set out above, there are no other matters that are required to be disclosed under Schedule 2 paragraph (g) of the AIM Rules in relation to the appointment of Mr. Barker.

Enquiries:

 
 MedaPhor Group plc                                                                                         www.medaph 
                                                                                                            or.com 
 Stuart Gall, CEO                                                                                      Tel: +44 (0) 29 
                                                                                                       2075 
                                                                                                       6534 
 
 Cenkos Securities                                                                                    Tel: +44 (0) 20 
                                                                                                      7397 
                                                                                                      8900 
 Bobbie Hilliam (Nominated 
  Advisor) 
 Michael Johnson / Julian 
  Morse (Corporate Broking) 
 
 Walbrook PR                                                                               Tel: [phone] or 
                                                                                               [e-mail] 
 Paul McManus / Anna                                                                   Mob: [phone] / Mob: 
  Dunphy                                                                                           [phone] 
 
 

About MedaPhor (www.medaphor.com)

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops advanced hi-fidelity haptic and manikin based training simulators, clinical image analysis software tools, augmented reality based needle guidance software and artificial intelligence based automated scanning software for all medical practitioners.

Based in Cardiff and Oxford in the UK and Atlanta in the US, MedaPhor is split into two divisions:

Ultrasound Simulation and Training

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Point-of-Care simulator platform (launching January 2018). Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound

Focuses on developing augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. ScanNav uses machine-learning based algorithms to automatically access and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAWGGQUUUPMGAU

(END) Dow Jones Newswires

October 30, 2017 11:19 ET (15:19 GMT)